Table 5. Bleeding events beyond 45 days post-operation to the end of follow-up.
Transcatheter LAA closure (n = 67) | Thoracoscopic LAA occlusion(n = 136) | HR (thoracoscopic
group/transcatheter group) |
95% CI | P | ||||
Events/
patient-years |
Observed rate:
events per 100 patient-years (95% CI) |
Events/
patient-years |
Observed rate:
events per 100 patient-years (95% CI) |
|||||
HR: hazard ratio; LAA: left atria appendage. | ||||||||
Total hemorrhage events | 4/124.0 | 3.2 (1.2−8.6) | 2/258.8 | 0.8 (0.2−3.1) | 0.246 | 0.074−0.819 | 0.022 | |
Digestive tract hemorrhage | 2/127.9 | 1.6 (0.4−6.3) | 1/259.9 | 0.4 (0.1−2.7) | 0.252 | 0.046−1.374 | 0.111 | |
Hematuria | 0/130.0 | 0 | 0/262.1 | 0 | − | − | − | |
Intracranial hemorrhage | 1/127.2 | 0.8 (0.1−5.5) | 0/262.1 | 0 | − | − | − | |
Nasal bleeding | 1/132.5 | 0.8 (0.1−5.6) | 1/261.0 | 0.4 (0.1−2.7) | 0.5 | 0.031−78.003 | 0.625 |